Novitas Capital (formerly PA Early Stage Partners is a venture capital firm that prospers because of their investment philosophy, their strong partner relationships, and their team who carries significant hands-on experience in successfully guiding companies to growth and value creation. For more than a decade, Novitas Capital has successfully invested in and generated returns on early-stage technology and life science companies.
At Novitas, they mine innovation and opportunities where funding for seed, start-up and early stage ventures is scarce. They discover companies at their earliest stages, thoroughly vet them and, upon typically leading investment rounds, take an active role in facilitating their success. The companies and ventures in which they invest are characterized by strong intellectual capital, proven leadership, breakthrough concepts, and unique positioning.
Based in Wayne, Pennsylvania, with offices in Pittsburgh, Pennsylvania, Allendale, New Jersey, and Morgantown, West Virginia, Novitas currently has approximately 30 active portfolio companies and manages approximately $237 million across three venture funds.
|Agile Therapeutics||7/12||Series C||$40M||6|
|TetraLogic Pharmaceuticals||8/10||Series C||$32M||8|
|Logical Therapeutics||5/10||Series C||$16.9M||3|
|BPL Global||10/09||Venture Round||$22M||3|
|BPL Global||8/08||Venture Round||$23M||3|
|TOA Technologies||6/08||Series C||$13M||3|
|BPL Global||2/07||Series C||$26M||7|